Terms: = Uterine cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Prognosis
21 results:
1. Transcriptome analysis of an AKT inhibitor-resistant endometrial cancer cell line.
Onishi T; Takashima T; Shibahara K; Takagi S; Tanaka S; Mori M; Odashima H; Osawa Y; Hattori M
Pharmacol Rep; 2024 Apr; 76(2):379-389. PubMed ID: 38478219
[TBL] [Abstract] [Full Text] [Related]
2. [Effects of preoperative diagnostic hysteroscopy on peritoneal cytology and prognosis in patients with non-endometrioid carcinoma].
Zhai ZY; Yang L; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):903-910. PubMed ID: 38123196
[No Abstract] [Full Text] [Related]
3. Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition.
Zhang Y; Li X; Gong Y; Du D; Chen H; Liu L; Cheng Z
Medicine (Baltimore); 2023 May; 102(20):e33834. PubMed ID: 37335710
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy.
Li JY; Park HS; Huang GS; Young MR; Ratner E; Santin A; Damast S
Gynecol Oncol; 2021 Dec; 163(3):557-562. PubMed ID: 34602287
[TBL] [Abstract] [Full Text] [Related]
5. Treatment outcomes and complications in FIGO stage IIIC and IVB endometrioid endometrial cancer patients presenting as nodal spreads following systematic lymphadenectomy and adjuvant therapy.
Kong TW; Jo E; Son JH; Paek J; Chang SJ; Ryu HS
J Obstet Gynaecol Res; 2021 Sep; 47(9):3322-3330. PubMed ID: 34196087
[TBL] [Abstract] [Full Text] [Related]
6. PET-CT radiomics by integrating primary tumor and peritumoral areas predicts E-cadherin expression and correlates with pelvic lymph node metastasis in early-stage cervical cancer.
Li XR; Jin JJ; Yu Y; Wang XH; Guo Y; Sun HZ
Eur Radiol; 2021 Aug; 31(8):5967-5979. PubMed ID: 33528626
[TBL] [Abstract] [Full Text] [Related]
7. Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer.
Tian X; Ge D; Zhang F; Zhang B; Bai W; Xu X; Li Z; Cao Y; Li P; Zou K; Zou L
Int J Cancer; 2021 Feb; 148(4):921-931. PubMed ID: 33113150
[TBL] [Abstract] [Full Text] [Related]
8. Comparative study on the oncological prognosis of laparoscopy and laparotomy for stage IIA1 cervical squamous cell carcinoma.
Chen C; Fang Z; Wang Q; Li W; Li P; Wang L; Kang S; Zhu B; Lin Z; Wang X; Wang L; Fan H; Bin X; Lang J; Liu P
Eur J Surg Oncol; 2021 Feb; 47(2):346-352. PubMed ID: 32859433
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic Role of Krüppel-Like Factors 5, 9, and 11 in Endometrial Endometrioid cancer.
Viola L; Londero AP; Bertozzi S; Orsaria M; Marzinotto S; Antoniazzi F; Renda V; Cinel J; Fruscalzo A; Lellé RJ; Mariuzzi L
Pathol Oncol Res; 2020 Oct; 26(4):2265-2272. PubMed ID: 32451988
[TBL] [Abstract] [Full Text] [Related]
10. Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the cdh1, TIMP3, and MGMT genes.
Teixeira da Costa Lodi C; Michelin MA; Miranda Lima MI; Murta EFC; Braga LDC; Montes L; Melo VH
Arch Gynecol Obstet; 2018 Nov; 298(5):971-979. PubMed ID: 30218185
[TBL] [Abstract] [Full Text] [Related]
11. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
[TBL] [Abstract] [Full Text] [Related]
12. Impact of Conservative Managements in Young Women With Grade 2 or 3 Endometrial Adenocarcinoma Confined to the Endometrium.
Gonthier C; Trefoux-Bourdet A; Koskas M
Int J Gynecol Cancer; 2017 Mar; 27(3):493-499. PubMed ID: 28187090
[TBL] [Abstract] [Full Text] [Related]
13. The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.
Wang XJ; Xiong Y; Ma ZB; Xia JC; Li YF
Chin J Cancer; 2016 Jun; 35(1):54. PubMed ID: 27311570
[TBL] [Abstract] [Full Text] [Related]
14. Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and cancer.
Milutin Gašperov N; Sabol I; Planinić P; Grubišić G; Fistonić I; Ćorušić A; Grce M
PLoS One; 2015; 10(6):e0129452. PubMed ID: 26057381
[TBL] [Abstract] [Full Text] [Related]
15. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and cdh1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract] [Full Text] [Related]
16. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma.
Romero-Pérez L; López-García MÁ; Díaz-Martín J; Biscuola M; Castilla MÁ; Tafe LJ; Garg K; Oliva E; Matias-Guiu X; Soslow RA; Palacios J
Mod Pathol; 2013 Nov; 26(11):1514-24. PubMed ID: 23743934
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract] [Full Text] [Related]
18. Clinical relevance of cdh1 and cdh13 DNA-methylation in serum of cervical cancer patients.
Abudukadeer A; Bakry R; Goebel G; Mutz-Dehbalaie I; Widschwendter A; Bonn GK; Fiegl H
Int J Mol Sci; 2012; 13(7):8353-8363. PubMed ID: 22942707
[TBL] [Abstract] [Full Text] [Related]
19. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
[TBL] [Abstract] [Full Text] [Related]
20. Promoter methylation of p16, DAPK, cdh1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics.
Jeong DH; Youm MY; Kim YN; Lee KB; Sung MS; Yoon HK; Kim KT
Int J Gynecol Cancer; 2006; 16(3):1234-40. PubMed ID: 16803511
[TBL] [Abstract] [Full Text] [Related]
[Next]
